€26.38
5.65% yesterday
Xetra, Nov 15, 05:24 pm CET
ISIN
DE000A3ENQ51
Symbol
1SXP
Index
Sector
Industry

SCHOTT Pharma Stock price

€26.48
-4.24 13.80% 1M
-5.34 16.78% 6M
-7.12 21.19% YTD
-1.40 5.02% 1Y
-4.82 15.40% 3Y
-4.82 15.40% 5Y
-4.82 15.40% 10Y
Xetra, Closing price Fri, Nov 15 2024
-1.48 5.29%
ISIN
DE000A3ENQ51
Symbol
1SXP
Index
Sector
Industry

Key metrics

Market capitalization €4.21b
Enterprise Value €4.28b
P/E (TTM) P/E ratio 28.00
EV/Sales (TTM) EV/Sales 4.52
P/S ratio (TTM) P/S ratio 4.44
P/B ratio (TTM) P/B ratio 5.49
Dividend yield 0.54%
Last dividend (FY24) €0.15
Revenue (TTM) Revenue €948.56m
EBIT (operating result TTM) EBIT €173.82m
Cash position €22.15m
EPS (TTM) EPS €1.00
Show more

Is SCHOTT Pharma a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.

SCHOTT Pharma Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a SCHOTT Pharma forecast:

4x Buy
36%
7x Hold
64%

Analyst Opinions

11 Analysts have issued a SCHOTT Pharma forecast:

Buy
36%
Hold
64%

Financial data from SCHOTT Pharma

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
949 949
-
100%
- Direct Costs 624 624
-
66%
324 324
-
34%
- Selling and Administrative Expenses 63 63
-
7%
- Research and Development Expense 27 27
-
3%
235 235
-
25%
- Depreciation and Amortization 61 61
-
6%
EBIT (Operating Income) EBIT 174 174
-
18%
Net Profit 150 150
-
16%

In millions EUR.

Don't miss a Thing! We will send you all news about SCHOTT Pharma directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

SCHOTT Pharma Stock News

EQS
about 2 months ago
SCHOTT Pharma AG & Co. KGaA (MDAX: 1SXP), ein Pionier für pharmazeutische Aufbewahrungs- und Verabreichungssysteme, Gerresheimer AG (MDAX: GXI) und Stevanato Group S.p.A. (NYSE: STVN) haben eine strategische Industrieallianz („Alliance for RTU") geschlossen, um die Marktakzeptanz von Ready-to-Use...
AD HOC NEWS
about 2 months ago
SCHOTT Pharma AG & Co. KGaA / DE000A3ENQ51
AD HOC NEWS
about 2 months ago
SCHOTT Pharma AG & Co. KGaA / DE000A3ENQ51
More SCHOTT Pharma News

Company Profile

Head office Germany
CEO Andreas Reisse
Founded 2022
Website www.schott.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today